• Reparixin: A CXCR1/2 Lens on IL-8 Biology

  2026-09-10

  Reparixin is a CXCR1/2 inhibitor that enables receptor-level analysis of IL-8 signaling across neutrophil, tissue-injury, and tumor models. This article translates recent MRSA extracellular-vesicle findings into practical assay decisions while distinguishing established evidence from proposed applications.

• From Cassava Stress Genes to Translational PCR Strategy

  2026-09-09

  A mechanistic and strategic guide to using endpoint PCR to validate stress-response genes, support TA cloning, and build more reproducible translational workflows around cassava A20/AN1 research.

• Cyclophosphamide: From Bioactivation to Assay Design

  2026-09-09

  Cyclophosphamide is an alkylating chemotherapeutic agent whose hepatic bioactivation makes experimental interpretation highly dependent on model context. This guide connects DNA damage biology, topotecan-based mechanistic insight, immune endpoints, and reproducible assay design.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-09-08

  A 2026 study provides a systematic murine assessment of ibotenic acid toxicity across behavioral, biochemical, histopathological, and immunohistochemical endpoints. Its findings distinguish reversible early responses at a lower exposure from severe toxicity, mortality, and neuronal injury markers at a higher exposure, helping define the compound’s acute toxicological window.

• H-89 and the PKA Gate in Wnt Bone Biology

  2026-09-08

  Wnt-driven osteogenesis is increasingly understood as a signaling–metabolism problem, not only a transcriptional one. This thought-leadership guide explains how H-89 can help translational researchers test the Ca2+-PKA-GFAT1 axis while preserving the controls needed to distinguish PKA-dependent biology from chemical-probe artifacts.

• Remdesivir (GS-5734): Mechanism and Evidence

  2026-09-07

  Remdesivir, also called GS-5734, is a phosphoramidate prodrug that delivers a nucleotide analogue to viral RNA-dependent RNA polymerases. Evidence spans coronavirus antiviral research, Ebola virus treatment research, and structural studies of viral polymerase complexes, but cell-based potency and animal protection do not establish efficacy against every RNA virus.

• Cholesterol for mRNA-LNP Research

  2026-09-07

  Cholesterol connects membrane biophysics with practical lipid nanoparticle workflows for localized mRNA delivery. This guide translates an intravesical p21 mRNA-LNP study into reproducible formulation, assay, and troubleshooting decisions while distinguishing validated findings from optimization recommendations.

• GSK-923295: A Strategic Probe of Mitotic Fidelity

  2026-09-04

  GSK-923295 offers translational researchers a chemically defined way to interrogate CENP-E motor function, chromosome alignment, and mitotic fidelity. By integrating CENP-E inhibition with emerging evidence on CTCF-dependent centromere architecture, this article outlines a practical framework for mechanistic studies, cancer research, and preclinical decision-making.

• Cholesterol for mRNA-LNP Membrane Research

  2026-09-04

  Learn how Cholesterol B1702 can improve the interpretability of lipid nanoparticle, membrane fluidity, and lipid metabolism experiments. This workflow translates localized p21 mRNA-LNP findings into practical formulation, assay-design, and troubleshooting decisions without overstating what the reference study directly demonstrated.

• Oligo (dT) 25 Beads: Practical mRNA Workflow

  2026-09-03

  Oligo (dT) 25 Beads support selective capture of polyadenylated eukaryotic mRNA from total RNA or animal and plant cell or tissue samples. They are appropriate for polyA-selected mRNA workflows, but not as a general substitute for total RNA purification or for samples dominated by non-polyadenylated or prokaryotic RNA.

• Liproxstatin-1 and the Next Ferroptosis Frontier

  2026-09-03

  Ferroptosis research is moving from redox initiation toward the plasma-membrane events that determine cell rupture. This thought-leadership guide positions Liproxstatin-1 as a mechanistic ferroptosis inhibitor for separating lipid-peroxide accumulation from membrane execution, while outlining translational strategies for renal injury and immuno-oncology models.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-09-02

  This study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and multiomic design clarifies why blocking monocyte-derived macrophages alone may produce limited remodeling of the immunosuppressive metastatic niche.

• MAPK10–KRT16 Signaling Suppresses NSCLC Metastasis

  2026-09-02

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its integrated cellular, animal, and clinical evidence supports a mechanistic model for biomarker development while indicating that pathway-specific validation remains necessary before therapeutic translation.

• MK-5108 (VX-689): From AURKA Biology to Assays

  2026-09-01

  MK-5108, also known as VX-689, is a highly selective Aurora A kinase inhibitor for cancer research. This article connects its biochemical selectivity with retinoblastoma evidence and shows how to design more informative cell and xenograft studies without overstating translational conclusions.

• AMG 9810 at the Metabolism–Pain Interface

  2026-09-01

  TRPV1 biology is usually framed through capsaicin, heat, protons, and sensory neuron excitability. A 2024 Autophagy study adds a strategic dimension: metabolic and lysosomal stress can reorganize AMPK–SQSTM1/p62–NFE2L2 signaling through feedback, redox, pH, and calcium-dependent mechanisms. This article explains how AMG 9810 can help translational researchers separate TRPV1-driven sensory signals from stress-adaptive cellular states, while defining the evidence boundaries between pain mechanism research and cancer metabolism.

8151 records 5/544 page Previous Next 12345 下5页 Last page